414 related articles for article (PubMed ID: 34925360)
21. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
[TBL] [Abstract][Full Text] [Related]
22. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
Edsfeldt A; Nitulescu M; Grufman H; Grönberg C; Persson A; Nilsson M; Persson M; Björkbacka H; Gonçalves I
Stroke; 2012 Dec; 43(12):3305-12. PubMed ID: 23150653
[TBL] [Abstract][Full Text] [Related]
23. Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.
Rasmussen LJH; Moffitt TE; Eugen-Olsen J; Belsky DW; Danese A; Harrington H; Houts RM; Poulton R; Sugden K; Williams B; Caspi A
J Child Psychol Psychiatry; 2019 Feb; 60(2):199-208. PubMed ID: 29741788
[TBL] [Abstract][Full Text] [Related]
24. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
25. Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy.
Wu CZ; Chang LC; Lin YF; Hung YJ; Pei D; Chu NF; Chen JS
Clin Biochem; 2015 Dec; 48(18):1324-9. PubMed ID: 26162494
[TBL] [Abstract][Full Text] [Related]
26. Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor).
Bourassa KJ; Rasmussen LJH; Danese A; Eugen-Olsen J; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE; Caspi A
Brain Behav Immun; 2021 Oct; 97():79-88. PubMed ID: 34224821
[TBL] [Abstract][Full Text] [Related]
27. suPAR: A New Biomarker for Cardiovascular Disease?
Hodges GW; Bang CN; Wachtell K; Eugen-Olsen J; Jeppesen JL
Can J Cardiol; 2015 Oct; 31(10):1293-302. PubMed ID: 26118447
[TBL] [Abstract][Full Text] [Related]
28. Soluble Urokinase Receptor and Acute Kidney Injury.
Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J
N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687
[TBL] [Abstract][Full Text] [Related]
29. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
[TBL] [Abstract][Full Text] [Related]
30. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
[TBL] [Abstract][Full Text] [Related]
31. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity.
Can U; Buyukinan M; Yerlikaya FH
Indian J Med Res; 2017 Mar; 145(3):327-333. PubMed ID: 28749394
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
35. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
36. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
[TBL] [Abstract][Full Text] [Related]
37. Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?
Scotti F; Milani P; Setaccioli M; Maestroni S; Sidenius N; De Lorenzi V; Massacesi A; Bergamini F; Zerbini G
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):899-903. PubMed ID: 30617582
[TBL] [Abstract][Full Text] [Related]
38. Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia.
Mölkänen T; Ruotsalainen E; Thorball CW; Järvinen A
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1417-24. PubMed ID: 21479972
[TBL] [Abstract][Full Text] [Related]
39. Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.
Friis Petersen J; Grynnerup AG; Mitchell NH; Løssl K; Sørensen S; Lindhard A; Friis-Hansen L; Pinborg A; Nyboe Andersen A; Løkkegaard E
J Reprod Immunol; 2020 Apr; 138():103103. PubMed ID: 32145561
[TBL] [Abstract][Full Text] [Related]
40. Association of the Circulating Supar Levels with Inflammation, Fibrinolysis, and Outcome in Severe Burn Patients.
Lin JC; Chen XD; Xu ZR; Zheng LW; Chen ZH
Shock; 2021 Dec; 56(6):948-955. PubMed ID: 34779798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]